Johnson & Johnson has dropped plans to develop its recently [...]
MSD, known as Merck & Co. in the US, says [...]
Analysis highlights potential for benefits far beyond obesity, signalling a [...]
Cemiplimab plus chemotherapy shows five-year survival benefit in advanced NSCLC Empower-lung 3 trial
Regeneron UK Limited has reported five-year follow-up results from the [...]
Symeres, a global contract research, development and manufacturing organization, has [...]
The National Institute for Health and Care Excellence (NICE) has [...]
Medable has launched Agent Studio, which it describes as the [...]
Resolution Therapeutics, a clinical-stage biopharmaceutical company developing regenerative macrophage therapy [...]
DeuterOncology, a clinical-stage biotech company developing deuterated cancer therapies, has [...]
Skye Bioscience has reached a key milestone in its CBeyond [...]